Start for free
Start for free
Verily logo

Verily

North America, California, United States, South San Francisco

Description

Verily is an Alphabet health tech company focused on research, care, and health financing to deliver on the promise of precision health.

Investor Profile

Verily has made 16 investments, with 0 in the past 12 months and 6% as lead.

Stage Focus

  • Series A (31%)
  • Series B (25%)
  • Series Unknown (19%)
  • Seed (13%)
  • Post Ipo Equity (6%)
  • Series C (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Cloud Data Services
  • Industrial Automation
  • Robotics
  • Health Diagnostics
  • Software
  • Medical
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Verily frequently co-invest with?

Mubadala
Mubadala
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 2
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
The Production Board (TPB)
The Production Board (TPB)
North America, California, United States, San Francisco
Co-Investments: 2
The E14 Fund
The E14 Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Craft Ventures
Craft Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Andreessen Horowitz
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 5
DCVC
DCVC
North America, California, United States, San Francisco
Co-Investments: 3
Section 32
Section 32
North America, California, United States, San Diego
Co-Investments: 7
Cultivian Sandbox Ventures
Cultivian Sandbox Ventures
North America, Illinois, United States, Chicago
Co-Investments: 2
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does Verily often collaborate with?

BD
Ben Davenport
North America, California, United States, Palo Alto
Shared Deals: 1
AW
Anne Wojcicki
North America, California, United States, San Francisco
Shared Deals: 1
SL
Steven Lurie
North America, California, United States, San Francisco
Shared Deals: 1
MD
Michael Dempsey
North America, New York, United States, New York
Shared Deals: 1
BB
Brook Byers
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Verily?

The Public Health Company

Palo Alto, California, United States

Developing the first global biosecurity platform to provide enterprises a SaaS-enabled service for the management of bio-risks.

BiotechnologySaaSSoftware
Series AMay 1, 2022
Amount Raised: $35,000,000
Syllable

Sunnyvale, California, United States

Syllable uses AI to transform the way healthcare systems initiate and cultivate relationships with patients.

Artificial Intelligence (AI)EducationHealth CareSoftware
Series CFeb 7, 2022
Amount Raised: $40,000,000
EQRx

Cambridge, Massachusetts, United States

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityDec 17, 2021
Amount Raised: $1,200,000,000
Culture Biosciences

San Francisco, California, United States

Culture Biosciences develops automated bio-reactors that help companies optimize their manufacturing processes.

BiotechnologyCloud Data ServicesIndustrial AutomationRobotics
Series BOct 14, 2021
Amount Raised: $80,000,000
The Public Health Company

Palo Alto, California, United States

Developing the first global biosecurity platform to provide enterprises a SaaS-enabled service for the management of bio-risks.

BiotechnologySaaSSoftware
SeedApr 29, 2021
Amount Raised: $8,000,000
Genalyte

San Diego, California, United States

Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.

BiotechnologyHealth CareHospital
Series UnknownJan 11, 2021
Amount Raised: $50,000,000
Culture Biosciences

San Francisco, California, United States

Culture Biosciences develops automated bio-reactors that help companies optimize their manufacturing processes.

BiotechnologyCloud Data ServicesIndustrial AutomationRobotics
Series AMar 4, 2020
Amount Raised: $15,000,000
Mammoth Biosciences

San Francisco, California, United States

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

BiotechnologyGeneticsHealth DiagnosticsLife Science
Series BJan 30, 2020
Amount Raised: $45,000,000
Freenome

South San Francisco, California, United States

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

BiotechnologyHealth CareHealth DiagnosticsPersonal Health
Series BJul 24, 2019
Amount Raised: $160,000,000
Culture Biosciences

San Francisco, California, United States

Culture Biosciences develops automated bio-reactors that help companies optimize their manufacturing processes.

BiotechnologyCloud Data ServicesIndustrial AutomationRobotics
Series UnknownFeb 12, 2019
Amount Raised: $5,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator